KT Group (n = 33) | Placebo Group (n = 33) | MD (95% CI) (lower limit, upper limit) | Cohen’s d | p-value | |
---|---|---|---|---|---|
Flexion JPE (0) | 0.77 | ||||
Baseline | 5.6 ± 1.4 | 5.1 ± 1.2 | 0.5 (− 0.1, 1.1) | 0.130 | |
3 days | 4.3 ± 1.5 | 5.0 ± 1.5 | 0.7 (−1.5, − 0.1) | 0.046 | |
7 days | 2.6 ± 1.2 | 4.7 ± 1.4 | 2.1 (1.4, 2.7) | < 0.001 | |
p-value | < 0.001 | 0.001 | |||
Extension JPE (0) | 0.85 | ||||
Baseline | 6.6 ± 1.6 | 6.33 ± 1.70 | 0.2 (−0.5, 1.0) | 0.508 | |
3 days | 5.5 ± 1.5 | 6.52 ± 1.50 | 1.0 (0.2, 1.7) | 0.010 | |
7 days | 3.5 ± 1.6 | 6.03 ± 1.94 | 2.4 (1.7, 3.3) | < 0.001 | |
p-value | < 0.001 | 0.003 | |||
LT Rotation (0) | 0.69 | ||||
Baseline | 5.3 ± 1.4 | 5.1 ± 1.3 | 0.2 (−0.4, 0.9) | 0.424 | |
3 days | 4.3 ± 1.3 | 4.9 ± 1.5 | 0.6 (− 0.0, 1.3) | 0.064 | |
7 days | 3.3 ± 1.0 | 4.8 ± 1.5 | 1.4 (0.8, 2.1) | < 0.001 | |
p-value | < 0.001 | 0.057 | |||
RT Rotation (0) | 0.59 | ||||
Baseline | 5.0 ± 1.3 | 4.7 ± 1.1 | 0.3 (−0.2, 0.9) | 0.289 | |
3 days | 4.0 ± 1.2 | 4.7 ± 1.3 | 0.6 (0.1, 1.3) | 0.034 | |
7 days | 2.9 ± 1.0 | 4.9 ± 1.2 | 1.9 (1.3, 2.4) | < 0.001 | |
p-value | < 0.001 | 0.008 | |||
Pain intensity (VAS) | 0.57 | ||||
Baseline | 5.46 ± 1.44 | 4.97 ± 1.42 | 0.49 (−0.21, 1.19) | 0.167 | |
3 days | 4.61 ± 1.40 | 4.89 ± 1.49 | 0.26 (− 0.44, 0.98) | 0.451 | |
7 days | 3.24 ± 0.91 | 4.64 ± 1.39 | 1.40 (0.82, 1.98) | < 0.001 | |
p-value | < 0.001 | 0.102 | |||
Functional Disability (NDI) | 0.03 | ||||
Baseline | 32.18 ± 9.50 | 31.45 ± 8.64 | 0.72 (−3.74, 5.19) | 0.746 | |
3 days | 31.90 ± 9.46 | 31.21 ± 8.63 | 0.69 (−3.75, 5.15) | 0.756 | |
7 days | 31.21 ± 8.43 | 31.27 ± 8.69 | 0.06 (−4.15, 4.27) | 0.977 | |
p-value | 0.009 | 0.045 |